Genetically engineered mice offer hope for isolating beta cells and treatment of type 2 diabetes

February 12, 2003

Bethesda, MD -- Diabetes mellitus (DM) affects at least 16 million Americans, ranks seventh as a cause of death in the United States, and costs the national economy over $100 billion yearly. About 95 percent of persons with DM have type 2.

Type 2 DM is characterized by insulin resistance in peripheral tissues as well as a defect in insulin secretion by beta cells. Insulin regulates carbohydrate metabolism by diminishing the rapid transport of glucose and amino acids from the circulation into muscle and other tissue cells, by promoting the storage of glucose in liver cells as glycogen, and by inhibiting gluconeogenesis. DM is often associated with other risk factors, including disorders of lipid metabolism, obesity, hypertension, and impairment of renal function.

In the last several decades Americans have increased their food consumption by an average of more than 200 calories, becoming a society with an alarming increase in obesity. The onset of type 2 diabetes has become an epidemic.

Type 2 diabetes cannot be cured, only controlled. Therefore, research into the insulin- producing beta cell (or -cell) of the pancreas, the predominant cell of the islets of Langerhans that secretes insulin, may offer a key into the development of diabetes mellitus, with anatomic and functional loss of these cells. One such effort entails the identification and characterization of embryonic or adult stem cells that give rise to the â-cell could lead to cellular-based therapies for treating both type 1 and 2 diabetes.

Previous studies have shown that green fluorescent protein (GFP) from the jellyfish Aequorea victoria and its yellow and cyan derivatives could be utilized as reporter genes to label specific cell types including pancreatic â-cells by expressing GFP under the control of a tissue-specific promoter. One advantage of these proteins is that they can be detected in living cells because they fluoresce brightly upon exposure to ultraviolet light or blue light without the addition of coactivators or external substances. In addition, pure populations of fluorescent-tagged cells can be isolated using a fluorescence-activated cell sorter.

Rat and human â-cells treated with adenovirus, with genes from different parental strains, expressing green fluorescent protein (GFP) under the control of the rat insulin I promoter, appear to function normally, suggesting that expression of GFP may be well tolerated by these cells. Therefore a team of researchers believed that if they could generate a mouse model where pancreatic â-cells were genetically tagged with GFP, they would have a potentially valuable research tool for studying â-cell biology, including the identification of progenitor cells.

A New Study
This study describes a line of transgenic mice in which the pancreatic â-cells are genetically tagged with GFP. The authors of "Transgenic Mice with Green Fluorescent Protein-labeled Pancreatic â-Cells" are Manami Hara, Xiaoyu Wang, Toshihiko Kawamura, Vytas P. Bindokas, Restituto F. Dizon, Sergio Y. Alcoser and Graeme I. Bell, all from the University of Chicago, Chicago, IL; and Mark Magnuson, Vanderbilt University, Nashville, TN. Their findings appear in the January 2003 edition of the American Journal of Physiology--Endocrinology and Metabolism.

Methodology
Purified transgene DNA was microinjected into the pronuclei of CD-1 mice by the Transgenic Mouse/ES Core Facility of the University of Chicago Diabetes Research and Training Center (DRTC). Procedures performed included glucose tolerance tests , insulin assays, isolation of pancreatic islets of Langerhans and preparation of single-cell suspensions from islets and pancreas.

The pancreas was removed, embedded in optimum cutting temperature compound and frozen in isopentane at 70°C. Serial sections were cut and fixed in four percent paraformaldehyde. GFP fluorescence is well retained under these conditions. The sections were stained with a polyclonal guinea pig anti-porcine insulin antibody to identify â-cells and with polyclonal rabbit anti-human glucagon, somatostatin, and pancreatic polypeptide antibodies to identify â- and PP-cells, respectively.

Results
This research produced transgenic mice in which pancreatic â-cells are genetically tagged with GFP. The phenotypic characterization of the MIP-GFP transgenic mice suggests that the presence of cytoplasmic GFP does not impair â-cell development or function, at least in the line of mice described in this report. Consequently, they envision a number of uses of these mice for studying â-cells in the body in isolation. In this regard, â-cell function can be studied in the MIP-GFP mice or in intercrosses with other genetically engineered and mutant mice.

These genetically engineered mice will be useful for isolating pancreatic â-cells at various stages of development from embryonic to adult. The purified â-cells can be used for molecular biological studies such as monitoring the changing pattern of gene expression during development with the use of microarrays or for biophysical studies of their functional properties.

Purified â-cells can be readily isolated from MIP-GFP mice, beginning with either islets or the pancreas. The ability to flow sort disassociated pancreatic cells to isolate them will facilitate studies of embryonic â-cells when islet isolation is very difficult. A second use of the MIP-GFP-transgenic mice is in studies where real-time instant identification of â-cells is required, such as in electrophysiological studies, as the â-cells can be distinguished from non-â-cells on the basis of their green fluorescence.

Conclusions
The mice developed in this study will be key in future studies of â-cell development. â-cell progenitors and/or stem cells have been described in ductal tissue, adult marrow, and embryonic stem cells, and the MIP-GFP mice may be useful in identifying the progenitor/stem cells in these tissues and cells. The preliminary data in this study reveal that these special laboratory animals can be used quantify the number of â-cells in the pancreas, and may be useful in following the changes in â-cells that occur in different physiological states such as pregnancy and diabetes.

Thus it may be possible to carry out a three-dimensional reconstruction of the distribution of islets within the entire pancreas of the MIP-GFP mice. In summary, the results of these efforts have generated a line of mice in which the â-cells are genetically tagged with GFP, an important first start in studying â-cells and islets in normal and diabetic states.
-end-
Source: January 2003 edition of the American Journal of Physiology--Endocrinology and Metabolism.

The American Physiological Society (APS) was founded in 1887 to foster basic and applied science, much of it relating to human health. The Bethesda, MD-based Society has more than 10,000 members and publishes 3,800 articles in its 14 peer-reviewed journals every year.

American Physiological Society

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.